Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
3.340
-0.420 (-11.17%)
At close: Apr 1, 2025, 4:00 PM
3.350
+0.010 (0.30%)
After-hours: Apr 1, 2025, 4:47 PM EDT

Olema Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-129.47-96.66-104.79-71.1-22.12
Upgrade
Depreciation & Amortization
0.390.380.360.160.01
Upgrade
Loss (Gain) From Sale of Assets
0.010.11---
Upgrade
Loss (Gain) From Sale of Investments
---0.28-
Upgrade
Stock-Based Compensation
22.5817.2618.8315.913.11
Upgrade
Other Operating Activities
-7.03-4.230.511.220.64
Upgrade
Change in Accounts Payable
2.512.320.35-0.68-0.22
Upgrade
Change in Other Net Operating Assets
6.65-2.912.673.51-1.29
Upgrade
Operating Cash Flow
-104.35-83.73-82.07-50.69-19.87
Upgrade
Capital Expenditures
-0.16--0.36-1.58-0.06
Upgrade
Sale of Property, Plant & Equipment
-0.01---
Upgrade
Investment in Securities
-93.37-4.8791.84-273.86-
Upgrade
Investing Cash Flow
-93.53-4.8591.48-275.44-0.06
Upgrade
Long-Term Debt Issued
----3.09
Upgrade
Net Debt Issued (Repaid)
----3.09
Upgrade
Issuance of Common Stock
275.48133.420.481.39221.19
Upgrade
Other Financing Activities
-6.66----
Upgrade
Financing Cash Flow
268.82133.420.481.39358.4
Upgrade
Net Cash Flow
70.9444.849.89-324.74338.48
Upgrade
Free Cash Flow
-104.51-83.73-82.43-52.27-19.92
Upgrade
Free Cash Flow Per Share
-1.78-1.85-2.06-1.32-2.84
Upgrade
Levered Free Cash Flow
-45.82-43.1-41.64-26.52-11.15
Upgrade
Unlevered Free Cash Flow
-45.82-43.1-41.64-26.52-10.74
Upgrade
Change in Net Working Capital
-20.27-4.87-6.4-3.660.35
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q